Episode 9: Demystifying the GPO with Mike Motto
August 21, 201445:40

Episode 9: Demystifying the GPO with Mike Motto

00:30 Mike’s work at a GPO.

00:45 There are two sides to the GPO business: the member side (pharmacies, hospitals), and the trade relations side.

1:00 Mike’s team was focused on the business partner development side of his work at the GPO, including work with a growing group called Specialty Pharmacy Solutions.

1:40 What is a GPO, and what does it do? A Group Purchasing Organization is an entity created to leverage the purchasing power of a group of individuals or businesses to obtain discounts from business partners that are based on the collective buying power of the GPO members.

2:45 Who would want to be in a GPO together? This can be split into two sides: the Acute side, which includes hospitals or integrated delivery networks, and the Post-Acute side, or the “Alternate Side Space,” which includes long-term care centers, specialty pharmacy, home infusion, home equipment, etc.

4:15 Most of the attention has been on the Post-Acute side with Accountable Care Organizations because the delivery of care can be most effective in these spaces.

4:50 How does purchasing in a GPO work? For pharmacies, it can mean being a one-stop shopping place.

7:15 How the Business Partner side of a GPO works.

8:45 How GPOs can help manufacturers get their products to reach a wider customer base.

10:40 An example of this in the pharmaceutical industry.

11:30 As an example, a GPO could help a company build a better marketing message as part of their partnership.

13:30 Two more advantages to working with a GPO include pushing a product to a wide potential consumer base, and possible extra sales support.

14:30 Why the value proposition of GPOs is being questioned.

15:35 Examples of some of the innovations offered by GPOs include reimbursement networks.

16:20 A few GPOs have even begun creating ACO networks.

17:00 For years, ACOs have been offering cost-effective healthcare, but didn’t have a good understanding of what a long-term care pharmacy provider, or specialty pharmacy provider, or a home-infusion provider does.

17:40 Automated Ordering Tools and the efficiency of ordering.

18:20 The importance of data analysis and collection.

19:00 Data analysis is invaluable when looking at things like re-hospitalization and the linkage between post-acute and acute in coordination.

20:00 The seven things a GPO can help membership with include: messaging, new distribution channel, the listserv, brand exposure, automated ordering, clinical support, data collection management and analysis, and lobbying in Washington.

20:50 A GPO can really be a market facilitator.

21:20 GPOs, typically, don’t prefer products, don’t create formularies, don’t create preferred situations of one product over another.

22:30 Many manufacturers never take advantage of a full engagement of what a GPO has to offer.

26:00 “Data becomes information, and information can become very instructive to creating strategy and really identifying patient type.”

27:00 There is a lot of very interesting emerging technology that could impact patient outcomes.

28:30 There is a strong movement for long-term care at home.

29:20 In the post-acute world, ACO networks are forming to be a voice for all post-acute providers, and making sure that that voice is heard.

30:30 How a hospital can prevent high percentages of patient readmission when they are fully coordinated in all aspects of data collection after patient discharge.

33:00 GPOs, through some avenues, can really be the voice of the post-acute world.

35:50 Potential gaps in GPOs that could benefit forward-thinking entrepreneurs: faster innovation may be one area.

38:35 How an organization can become a business partner in a GPO.

40:30 What Mike is up to now.

 

You can find Michael LinkedIn here

gpo,aco,
|
|

Episode Support Provided By

Special Thanks to Our 2026 Sustaining Monthly Donors

Marilyn Bartlett, Kimberly Carleson, Dylan Yahn, Benjamin Light, Matt McQuide, Ann Kempski, Spencer Allen, Scott Tromanhauser, Steven Elkins, Matthew Bunte, Lori Smith, Dr. Scott Conard, Vivian Ho and Casey Cormier

Recent Episodes

EP536: Operationalizing the Architecture of Primary Care Patient Experience, With Rebecca Andrews, MD
Relentless Health ValueNovember 04, 2026
536
37:5134.64 MB

EP536: Operationalizing the Architecture of Primary Care Patient Experience, With Rebecca Andrews, MD

Listen On Your Favorite App Stacey: If you are a plan sponsor thinking about, for example, primary care as a way to optimize healthcare spend, do know that any given plan sponsor will really only get maximum possible benefit from an investment in primary care, advanced primary care, when and only wh...

EP535: When Patient Experience Means Parking and Pianos, Plan Sponsors Pay for Hotels, Not Outcomes—What to Measure Instead, With Robyn Leone
Relentless Health ValueOctober 28, 2026
535
37:1834.15 MB

EP535: When Patient Experience Means Parking and Pianos, Plan Sponsors Pay for Hotels, Not Outcomes—What to Measure Instead, With Robyn Leone

LIsten on Your Favorite App On episode 532 a few weeks ago, Chris Klomp from HHS was talking about ER (emergency room) usage as a signal, not just a statistic. If too many folks show up in the ER, consider this a signal that there's something missing. It means a patient who doesn't have access to pr...

EP534: The One Question to Test if a TPA Is Actually Independent, With Kimberly Carleson
Relentless Health ValueOctober 21, 202608:538.13 MB

EP534: The One Question to Test if a TPA Is Actually Independent, With Kimberly Carleson

Listen On Your Favorite App Here's a question I have heard more than once: What is a practical, speedy way to assess whether a TPA (third-party administrator) is truly independent and willing to protect the plan's interests, this plan sponsor's interests, versus being captive to, for example, networ...

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio
Relentless Health ValueOctober 14, 2026
533
37:1334.07 MB

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio

Hello, all you Relentless Tribe members. Thanks for hanging with me today to talk about a bunch of things. One of them being what exactly are level-funded plans, and what are the upsides, and then what are the risks? Because here's the thing. I was talking to an employer the other day, an employer w...

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp
Relentless Health ValueOctober 07, 2026
532
37:2034.17 MB

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp

Listen on Your Favorite App Today we are dipping into the archives for an essential replay from 2016, one decade ago, featuring Chris Klomp back when he served as CEO of a company called Collective Medical. With the nomination of Chris Klomp to serve as deputy secretary of the Department of Health a...

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson
Relentless Health ValueSeptember 30, 2026
531
38:0634.88 MB

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson

Listen on Your Favorite App Today, Evan Anderson and I are talking about carrier networks, how they started, how it's going. Because irrespective of whatever the plan was at the very beginning, any given network, especially talking about the big status quo networks, has evolved into what I'll call a...

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh
Relentless Health ValueSeptember 23, 2026
530
37:4534.56 MB

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh

Listen on Your Favorite App Hello, all you Relentless Tribe members. Thanks for hanging with me this week. When a self-insured plan sponsor sees an infusion claim hit their high-cost case report, and a lot of these infusions are really expensive, so many of them hit the high-cost claim report. For a...

Listen and Follow

Sponsored by Aventria Health Group
©2026 BD Bridges LLC. All Rights Reserved.